This topic contains a solution. Click here to go to the answer

Author Question: When assessing and managing a patient who is unresponsive, your highest priority should be: A) ... (Read 111 times)

RODY.ELKHALIL

  • Hero Member
  • *****
  • Posts: 591
When assessing and managing a patient who is unresponsive, your highest priority should be:
 
  A) preventing seizures.
  B) maintaining the airway, breathing, and circulation.
  C) assessing the patient for signs and symptoms of a stroke.
  D) administering oral glucose paste.

Question 2

A critical patient's vital signs should be reassessed at least every ________ minutes.
 
  A) 5
  B) 10
  C) 15
  D) 20



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kingfahad97

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

B

Answer to Question 2

A




RODY.ELKHALIL

  • Member
  • Posts: 591
Reply 2 on: Jul 2, 2018
YES! Correct, THANKS for helping me on my review


daiying98

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library